NEW YORK (GenomeWeb News) — Epitome Biosystems has received a $500,000 Phase IIB Small Business Innovation Research grant from the National Science foundation, the company said today.
 
Epitome will use the cash to help it develop a technology that measures ”key tyrosine phosphorylation sites that have important roles in many cellular and drug responses,” the company said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.